Moderna (MRNA) Stock Statistics & Valuation Metrics

Moderna has a market cap or net worth of $9.86B. The enterprise value is $6.31B.

Moderna has 389,079,740 shares outstanding. The number of shares has decreased by -2.65% in one year.

Moderna’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -32.53%.

The current PE Ratio of Moderna is ―. Moderna’s PEG ratio is ―.

In the last 12 months, Moderna had revenue of 3.20B and earned -3.56B in profits. Earnings per share was -9.27.

In the last 12 months, operating cash flow was -2.70B and capital expenditures -803.00M, giving a free cash flow of -3.50B billion.

Moderna pays an annual dividend of ―, resulting in a dividend yield of ―

Moderna upcoming earnings date is Oct 30, 2025, Before Open (Confirmed).

Moderna as a current ratio of 3.67, with Debt / Equity ratio of 7.88%

In the past 12 months, Moderna has paid -46.00M in taxes.

Moderna EV to EBITDA ratio is -4.36, with an EV/FCF ratio of -3.65.

Moderna has $5.13B in cash and marketable securities with $741.00M in debt, giving a net cash position of -$4.39B billion.

Gross margin is 52.22%, with operating margin of -123.32%, and net profit margin of -111.32%.

The average price target for Moderna is $46.00, which is 11.43% higher than the current price. The consensus rating is Hold